Trouble in Kobayashi’s Functional Food: The Mysterious Deaths in Japan
Công ty dược phẩm Nhật Bản Kobayashi thông báo đã xác nhận trường hợp tử vong thứ 5 có thể liên quan đến thực phẩm chức năng làm từ men gạo đỏ của hãng, được cho là giúp làm giảm cholesterol xấu.
An Unexplained Tragedy
The Japanese pharmaceutical company, Kobayashi, has announced that the fifth death case might be linked to their functional food made from red yeast rice. This product is believed to reduce bad cholesterol. The victims, aged between 70 and 90, were among 680 individuals who reported symptoms possibly related to the consumption of this functional food.
In response to the situation, Kobayashi has pledged compensation for the affected families, as well as the 114 hospitalized individuals. The company is taking responsibility and working on resolving the issue.
Unraveling the Mystery
Both the Ministry of Health in Japan and Kobayashi conducted an investigation into the matter. The company’s internal examination revealed the presence of puberulic acid in their red yeast rice products, a natural compound derived from blue mold. This unexpected finding has raised concerns about its potential impact on consumer health.
Kobayashi stated that further research is needed to determine whether puberulic acid is connected to the reported health issues. The Ministry of Health will collaborate with the company to conduct additional tests on this substance.
Thực phẩm chức năng chứa men gạo đỏ của công ty Kobayashi (Ảnh: Guardian)
Business Today: Delivering Reliable Information
As a trusted financial expert, Business Today aims to provide reliable news and updates to its readers. Our team closely monitors significant developments in finance and economics to offer valuable insights.
For more information on this topic or other finance-related matters, visit Business Today, your go-to source for accurate and up-to-date news.
Related News
Nhật Bản thu hồi thực phẩm chức năng khiến 2 người chết
VTV.vn – Nhà chức trách Nhật Bản cho biết nước này đã ghi nhận 2 trường hợp tử vong và 106 trường hợp nhập viện liên quan đến thực phẩm chức năng của hãng dược Kobayashi.